share_log

CASI Pharmaceuticals Analyst Ratings

CASI Pharmaceuticals Analyst Ratings

CASI 制药分析师评级
Benzinga ·  2023/08/14 06:35
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/14/2023 329.18% HC Wainwright & Co. → $10 Reiterates Buy → Buy
05/22/2023 329.18% HC Wainwright & Co. → $10 Reiterates Buy → Buy
11/16/2022 329.18% BTIG $21 → $10 Maintains Buy
11/15/2022 329.18% HC Wainwright & Co. $12 → $10 Maintains Buy
08/15/2022 415.02% HC Wainwright & Co. $3 → $12 Maintains Buy
06/03/2022 801.29% BTIG $4 → $21 Maintains Buy
05/16/2022 28.76% HC Wainwright & Co. $4 → $3 Maintains Buy
05/18/2021 71.67% BTIG → $4 Initiates Coverage On → Buy
05/14/2021 71.67% HC Wainwright & Co. $3.5 → $4 Maintains Buy
04/26/2021 63.09% Mizuho → $3.8 Initiates Coverage On → Buy
10/23/2020 114.59% Oppenheimer → $5 Initiates Coverage On → Outperform
03/24/2020 50.21% HC Wainwright & Co. $7 → $3.5 Maintains Buy
日期 上行/下行 分析公司 目标价格变动 评级变动 之前/当前的评级
08/14/2023 329.18% HC Wainwright & Co. → 10 美元 重申 购买 → 购买
05/22/2023 329.18% HC Wainwright & Co. → 10 美元 重申 购买 → 购买
11/16/2022 329.18% BTIG 21 美元 → 10 美元 维护 购买
11/15/2022 329.18% HC Wainwright & Co. 12 美元 → 10 美元 维护 购买
08/15/2022 415.02% HC Wainwright & Co. 3 美元 → 12 美元 维护 购买
06/03/2022 801.29% BTIG 4 美元 → 21 美元 维护 购买
05/16/2022 28.76% HC Wainwright & Co. 4 美元 → 3 美元 维护 购买
05/18/2021 71.67% BTIG → 4 美元 启动覆盖范围开启 → 购买
05/14/2021 71.67% HC Wainwright & Co. 3.5 美元 → 4 美元 维护 购买
04/26/2021 63.09% 瑞穗 → 3.8 美元 启动覆盖范围开启 → 购买
2020 年 10 月 23 日 114.59% 奥本海默 → 5 美元 启动覆盖范围开启 → 跑赢大盘
2020 年 3 月 24 日 50.21% HC Wainwright & Co. 7 美元 → 3.5 美元 维护 购买

What is the target price for CASI Pharmaceuticals (CASI)?

CASI Pharmicals(CASI)的目标价格是多少?

The latest price target for CASI Pharmaceuticals (NASDAQ: CASI) was reported by HC Wainwright & Co. on August 14, 2023. The analyst firm set a price target for $10.00 expecting CASI to rise to within 12 months (a possible 329.18% upside). 5 analyst firms have reported ratings in the last year.

HC Wainwright & Co. 于2023年8月14日公布了CASI Pharmicals(纳斯达克股票代码:CASI)的最新目标股价。这家分析公司将目标股价定为10.00美元,预计CASI将在12个月内升至10.00美元(可能上涨329.18%)。去年有5家分析公司公布了评级。

What is the most recent analyst rating for CASI Pharmaceuticals (CASI)?

CASI Pharmicals(CASI)的最新分析师评级是多少?

The latest analyst rating for CASI Pharmaceuticals (NASDAQ: CASI) was provided by HC Wainwright & Co., and CASI Pharmaceuticals reiterated their buy rating.

CASI Pharmicals(纳斯达克股票代码:CASI)的最新分析师评级由HC Wainwright & Co. 提供,CASI Pharmicals重申了他们的买入评级。

When is the next analyst rating going to be posted or updated for CASI Pharmaceuticals (CASI)?

CASI Pharmicals(CASI)的下一个分析师评级将在何时公布或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CASI Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CASI Pharmaceuticals was filed on August 14, 2023 so you should expect the next rating to be made available sometime around August 14, 2024.

分析师在进行了广泛的研究(包括浏览公开财务报表、与CASI Pharmicals的高管和客户交谈以及听取财报电话会议)后得出股票评级。大多数分析师每三个月进行一次评级,因此每家公司每年应该获得4个评级。CASI Pharmicals的最新评级是在2023年8月14日提交的,因此您应该预计下一个评级将在2024年8月14日左右公布。

Is the Analyst Rating CASI Pharmaceuticals (CASI) correct?

分析师对CASI Pharmicals(CASI)的评级是否正确?

While ratings are subjective and will change, the latest CASI Pharmaceuticals (CASI) rating was a reiterated with a price target of $0.00 to $10.00. The current price CASI Pharmaceuticals (CASI) is trading at is $2.33, which is within the analyst's predicted range.

尽管评级是主观的,将会发生变化,但最新的CASI Pharmicals(CASI)评级得到了重申,目标股价为0.00美元至10.00美元。CASI Pharmicals(CASI)目前的交易价格为2.33美元,在分析师的预测区间内。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发